BioSpace News Archive

9 Meters Biopharma, Inc. announced today that the company will deliver a poster presentation highlighting vurolenatide and will host a booth exhibit at the in-person component of the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting, held in a hybrid format both virtually and in Las Vegas, Nevada on October 22 - 27, 2021.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2021 after the market close on Tuesday, November 9th, 2021.

Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infection, in order to help achieve global TB elimination targets by increasing access to easy and reliable TB testing, especially in high burden countries, low-resource regions.

Krystal Biotech Inc. today announced the presentation of pre-clinical data describing the nonclinical pharmacology of nebulized KB407, a redosable gene therapy candidate for the treatment of cystic fibrosis, in a poster at the North American Cystic Fibrosis Conference (NACFC) taking place virtually November 2 – 5, 2021.

Zynerba Pharmaceuticals , Inc. today announced the presentation of a poster at the 2021 National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit being held virtually October 18-19, 2021.

Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), in collaboration with Professor Toni Cathomen, scientific director at the Center for Chronic Immunodeficiency Medical Center at the University of Freiburg, Germany, will present two oral presentations at the European Society of Gene and Cell Therapy (ESGCT) Congress to be held virtually from October 19-22, 2021.

Quantum-Si Incorporated, a life science tools company commercializing a unique protein sequencing platform, announced that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners.

Aadi Bioscience, Inc. announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., will present at H.C. Wainwright’s 2nd Annual Precision Oncology Conference, which will be held virtually.

Genesis Research, the leading Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) company, announces new enhancements to EVID AI, the world’s largest current healthcare literature research platform, that helps pharma teams and other healthcare decision makers find high quality, targeted results faster, more efficiently and from an unprecedented breadth of sources.